Prince Pharmaceutical Co., Ltd. (6935)
TWSE TWSE Primary Summary
Prince Pharmaceutical Co., Ltd. (6935) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Prince Pharmaceutical Co., Ltd. ever had a stock split?
Prince Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | TWSE Exchange | TW0006935000 ISIN |
| Taiwan Country | 210 Employees | 1 Jul 2026 Last Dividend | - Last Split | - IPO Date |
Overview
Prince Pharmaceutical Co., Ltd., established in 1962 and with its headquarters located in Yunlin, Taiwan, is a leading producer and distributor of vitamin B1 active pharmaceutical ingredients (APIs). The company has successfully expanded its market reach beyond Taiwan, establishing a strong presence in Japan, Spain, and various European countries. With over half a century of experience in the pharmaceutical industry, Prince Pharmaceutical Co., Ltd. continues to be at the forefront of vitamin B1 API production, catering to a diverse range of international clients.
Products and Services
- Vitamin B1 Active Pharmaceutical Ingredients (APIs)
Prince Pharmaceutical Co., Ltd. specializes in the production and sale of high-quality vitamin B1 active pharmaceutical ingredients, catering to the pharmaceutical industry's needs. Vitamin B1 APIs are crucial for various applications, including nutritional supplements and medication formulations, ensuring efficacy and safety standards are met.
